Article
Gene therapy for primary immunodeficiencies
18 Dec 2020
Abstract excerpt
Primary immunodeficiencies (PIDs) are a group of rare inherited disorders of the immune system. Many PIDs are devastating and require a definitive therapy to prevent progressive morbidity and premature mortality. Allogeneic haematopoietic stem cell transplantation (alloHSCT) is curative for many PIDs, and while advances have resulted in improved outcomes, the procedure still carries a risk of mortality and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
